Imen Khammari
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Imen Khammari has a total of 42 co-authors. Here are the top co-authors by number of shared publications:
Akila Fathallah
Department of Parasitology-Mycology Faculty of Medicine of Sousse University of Sousse Sousse Tunisia
4 shared publicationsHamed Chouaieb
Department of Parasitology-Mycology Faculty of Medicine of Sousse University of Sousse Sousse Tunisia
3 shared publicationsAlia Yaacoub
2 shared publicationsFatma Saghrouni
Research Unit, UR12SP34, Farhat Hached University Hospital, Ibn Jazzar Street, Sousse 4000, Tunisia
2 shared publicationsI. Bougmiza
Department of Family and Community Medicine Faculty of Medicine of Sousse Sousse Tunisia
2 shared publicationsJ. Boukadida
Research Unit (UR12SP34) Farhat Hached University Hospital Sousse Tunisia
2 shared publications
Latest Publications
- 7 May 2025
- Published by American Society of Tropical Medicine and Hygiene in The American Journal of Tropical Medicine and Hygiene
- Vol. 112 (5) , 966-969
Mucosal Leishmaniasis in Tunisia: Observations from a Rare Case Report
: Mucosal leishmaniasis (ML) is a parasitic disease affecting the mucosa of the upper respiratory tract and oral cavity. It is most prevalent in Central and South America, whereas cases in the Old World are relatively rare. Herein, we present the case of an immunocompetent man from Tunisia with a long-delayed diagnosis of ML, characterized by lesions in the nasal mucosa without cutaneous involvement. This report underlines the importance of multidisciplinary care and adherence to follow-up in managing this disease. Clinicians should remain vigilant regarding this parasitosis, its potential complications, and the need for accurate diagnosis and treatment.
- 7 May 2025
- Published by American Society of Tropical Medicine and Hygiene in The American Journal of Tropical Medicine and Hygiene
- Vol. 112 (5) , 966-969
Mucosal Leishmaniasis in Tunisia: Observations from a Rare Case Report
: Mucosal leishmaniasis (ML) is a parasitic disease affecting the mucosa of the upper respiratory tract and oral cavity. It is most prevalent in Central and South America, whereas cases in the Old World are relatively rare. Herein, we present the case of an immunocompetent man from Tunisia with a long-delayed diagnosis of ML, characterized by lesions in the nasal mucosa without cutaneous involvement. This report underlines the importance of multidisciplinary care and adherence to follow-up in managing this disease. Clinicians should remain vigilant regarding this parasitosis, its potential complications, and the need for accurate diagnosis and treatment.
- Open Access
- 1 January 2023
- Published by Polaris in Journal of Medical Sciences and Interdisciplinary Research
- Vol. 3 (1) , 30-40
Genetic Sequencing-Based Analysis of Virulence Determinants in Entamoeba Species
Amoebiasis remains a notable invasive infection affecting both the intestinal and extraintestinal systems. The present investigation aims to explore the epidemiological characteristics of intestinal amoebiasis among a cohort of 296 stool samples collected from Iraqi patients. In this investigation, PCR analysis was performed on samples from 296 individuals who were identified as microscopically positive. Molecular diagnostics revealed the presence of Entamoeba (E.) histolytica in 144 cases (48.64%), E. dispar in 91 cases (30.74%), and E. moskovski in 52 cases (17.56%). Coinfection with E. histolytica and E. dispar was noted in 9 cases (3.04%). PCR-positive isolates were further analyzed to determine the presence of E. histolytica virulence markers, with 61 samples (42.36%) testing positive for the cysteine proteases gene, 50 (34.72%) for the amoebapore gene, and 33 (22.91%) for the lectin gene. Sequencing of these virulence genes-cysteine protease, amoebapore, and Gal/GalNAc lectinin locally obtained E. histolytica strains revealed nucleotide homology as well as mutational substitutions across all three genes. Phylogenetic analysis of the partial sequence of the cysteine protease gene indicated close genetic proximity to the E. histolytica strain (M27307.1) listed in the NCBI-BLAST database, with observed genetic variation ranging from 0.0020% to 0.0050%. A similar analysis based on the partial sequence of the amoebapore B gene demonstrated alignment with the E. histolytica strain (MS30-1047), with a variation range of 0.020% to 0.050%. In addition, phylogenetic reconstruction using partial sequences of the Gal/GalNAc lectin gene from local isolates revealed a close genetic relationship to the E. histolytica HM-1:IMSS strain (AP023115.1), with differences ranging from 0.0080% to 0.0020%.
- 1 January 2023
- Published by Polaris in Journal of Medical Sciences and Interdisciplinary Research
- Vol. 3 (1) , 30-40
Open AccessGenetic Sequencing-Based Analysis of Virulence Determinants in Entamoeba Species
Amoebiasis remains a notable invasive infection affecting both the intestinal and extraintestinal systems. The present investigation aims to explore the epidemiological characteristics of intestinal amoebiasis among a cohort of 296 stool samples collected from Iraqi patients. In this investigation, PCR analysis was performed on samples from 296 individuals who were identified as microscopically positive. Molecular diagnostics revealed the presence of Entamoeba (E.) histolytica in 144 cases (48.64%), E. dispar in 91 cases (30.74%), and E. moskovski in 52 cases (17.56%). Coinfection with E. histolytica and E. dispar was noted in 9 cases (3.04%). PCR-positive isolates were further analyzed to determine the presence of E. histolytica virulence markers, with 61 samples (42.36%) testing positive for the cysteine proteases gene, 50 (34.72%) for the amoebapore gene, and 33 (22.91%) for the lectin gene. Sequencing of these virulence genes-cysteine protease, amoebapore, and Gal/GalNAc lectinin locally obtained E. histolytica strains revealed nucleotide homology as well as mutational substitutions across all three genes. Phylogenetic analysis of the partial sequence of the cysteine protease gene indicated close genetic proximity to the E. histolytica strain (M27307.1) listed in the NCBI-BLAST database, with observed genetic variation ranging from 0.0020% to 0.0050%. A similar analysis based on the partial sequence of the amoebapore B gene demonstrated alignment with the E. histolytica strain (MS30-1047), with a variation range of 0.020% to 0.050%. In addition, phylogenetic reconstruction using partial sequences of the Gal/GalNAc lectin gene from local isolates revealed a close genetic relationship to the E. histolytica HM-1:IMSS strain (AP023115.1), with differences ranging from 0.0080% to 0.0020%.
- Open Access
- 1 January 2021
- Published by Polaris in Interdisciplinary Research in Medical Sciences Specialty
- Vol. 1 (2) , 1-7
Evaluating the “Recomline Toxoplasma IgM” Kit for Differentiating Toxoplasmic and Natural IgM
Serology is mostly used to diagnose toxoplasmosis by methodically looking for anti-toxoplasmic IgG and IgM. The difference between anti-Toxoplasma IgM and non-specific IgM, referred to as "natural," is one of the challenges in interpreting Toxoplasma serology in pregnant women. This study aimed to assess the diagnostic efficacy of the "recomLine Toxoplasma IgM" immunoblot assay (Mikrogen, Diagnostik) in differentiating between normal IgM and specific anti-Toxoplasma IgM. Tests have been performed on 58 pregnant women's sera. ELISA-IgM was positive for all of these sera, while ELISA-IgG and IFI-IgG were negative. These sera are separated into two categories: Group 1: 30 sera were found to have natural IgM following three-week inspections for a maximum of three months. 28 sera with particular anti-toxoplasmic IgM were in group 2. The recomLine Toxoplasma IgM assay was used by the immunoblot kit to test the 28 sera. The eight recombinant toxoplasmic antigens that this test is based on are ROP1c, MIC3, GRA7, GRA8, p30, MAG1, GRA1, and rSAG1. Of the 28 confirmed IgM-specific sera, 11 had a sensitivity of 39.3% [22.1-59.3] in recomLine Toxoplasma IgM, while 28 of the 30 confirmed natural IgM sera had a specificity of 93.33% [76.5-98.8]. When IgM is positive and IgG is negative, the recomLine Toxoplasma IgM test can be recommended. The test's positive result increases the likelihood of a Toxoplasma seroconversion diagnosis, while its negative result does not rule it out. The test's positive predictive value was 84.6% [53.7-97.3] and its negative predictive value was 62.2% [46.5-75.8].
- 1 January 2021
- Published by Polaris in Interdisciplinary Research in Medical Sciences Specialty
- Vol. 1 (2) , 1-7
Open AccessEvaluating the “Recomline Toxoplasma IgM” Kit for Differentiating Toxoplasmic and Natural IgM
Serology is mostly used to diagnose toxoplasmosis by methodically looking for anti-toxoplasmic IgG and IgM. The difference between anti-Toxoplasma IgM and non-specific IgM, referred to as "natural," is one of the challenges in interpreting Toxoplasma serology in pregnant women. This study aimed to assess the diagnostic efficacy of the "recomLine Toxoplasma IgM" immunoblot assay (Mikrogen, Diagnostik) in differentiating between normal IgM and specific anti-Toxoplasma IgM. Tests have been performed on 58 pregnant women's sera. ELISA-IgM was positive for all of these sera, while ELISA-IgG and IFI-IgG were negative. These sera are separated into two categories: Group 1: 30 sera were found to have natural IgM following three-week inspections for a maximum of three months. 28 sera with particular anti-toxoplasmic IgM were in group 2. The recomLine Toxoplasma IgM assay was used by the immunoblot kit to test the 28 sera. The eight recombinant toxoplasmic antigens that this test is based on are ROP1c, MIC3, GRA7, GRA8, p30, MAG1, GRA1, and rSAG1. Of the 28 confirmed IgM-specific sera, 11 had a sensitivity of 39.3% [22.1-59.3] in recomLine Toxoplasma IgM, while 28 of the 30 confirmed natural IgM sera had a specificity of 93.33% [76.5-98.8]. When IgM is positive and IgG is negative, the recomLine Toxoplasma IgM test can be recommended. The test's positive result increases the likelihood of a Toxoplasma seroconversion diagnosis, while its negative result does not rule it out. The test's positive predictive value was 84.6% [53.7-97.3] and its negative predictive value was 62.2% [46.5-75.8].
- Open Access
- 30 April 2018
- Published by Bentham Science Publishers Ltd. in The Open Parasitology Journal
- Vol. 6 (1) , 1-6
Hydatid Recurrence Medically Treated by Albendazole
Introduction: Hydatidosis or Cystic Echinococcosis (CE) is a highly endemic parasitosis in Tunisia. The combination of surgery with an adjuvant anti-hydatid medical treatment was shown to reduce the risk of relapses, recurrences and post-operative complications. Case Report: We report the case of a liver hydatid cyst recurrence in a woman hospitalized for acute cholangitis of hydatid origin. The patient had a resection of the protruding dome and a bipolar drainage of the main bile duct and cystic cavity with a postoperative biliary fistula and a collection of the residual cavity that required endoscopic sphincterotomy. The patient was then followed up every 6 months. Three years after the intervention, CT scan showed a hydatid recurrence of two new liver cysts. Surgery was expected to be difficult and risky. Medical treatment with albendazole was decided before surgery. The CT scan performed after 9 months showed important regression of two hydatic cysts. Medical treatment has been extended. Two years later, CT scan was in favor of an involuted aspect of both cysts. The treatment of CE is primarily surgical; medical treatment alone or associated with surgery can be a good alternative, especially in case of hydatid recurrence and when surgery is risky, mainly in stage I hydatic cyst.
- 30 April 2018
- Published by Bentham Science Publishers Ltd. in The Open Parasitology Journal
- Vol. 6 (1) , 1-6
Open AccessHydatid Recurrence Medically Treated by Albendazole
Introduction: Hydatidosis or Cystic Echinococcosis (CE) is a highly endemic parasitosis in Tunisia. The combination of surgery with an adjuvant anti-hydatid medical treatment was shown to reduce the risk of relapses, recurrences and post-operative complications. Case Report: We report the case of a liver hydatid cyst recurrence in a woman hospitalized for acute cholangitis of hydatid origin. The patient had a resection of the protruding dome and a bipolar drainage of the main bile duct and cystic cavity with a postoperative biliary fistula and a collection of the residual cavity that required endoscopic sphincterotomy. The patient was then followed up every 6 months. Three years after the intervention, CT scan showed a hydatid recurrence of two new liver cysts. Surgery was expected to be difficult and risky. Medical treatment with albendazole was decided before surgery. The CT scan performed after 9 months showed important regression of two hydatic cysts. Medical treatment has been extended. Two years later, CT scan was in favor of an involuted aspect of both cysts. The treatment of CE is primarily surgical; medical treatment alone or associated with surgery can be a good alternative, especially in case of hydatid recurrence and when surgery is risky, mainly in stage I hydatic cyst.
- 27 November 2014
- Published by Wiley in Parasite Immunology
- Vol. 36 (12) , 684-693
Identification of soluble and membrane antigenic markers of acquired toxoplasmosis by immunoblot
Summary: The overall performance of quantitative assays in the detection of anti‐ToxoplasmaIgG is satisfactory, but discrepancies between assays are not uncommon especially when IgG concentrations are close to the limit of detection of the tests. The purpose of our study was to identify soluble and membrane antigens extracted fromToxoplasma gondiitachyzoites by immunoblot to select the most relevant antigenic bands to be used for qualitative serodiagnosis of acquired toxoplasmosis. We selected five relevant bands (98, 36, 33, 32 and 21 kDa) with soluble antigens and four relevant bands (42, 35, 32 and 30 kDa) with membrane antigens which gave high sensitivity and/or specificity in immunodiagnosis. The association on the same blot of at least three of the five relevant bands in the soluble antigen immunoblot showed the highest sensitivity/specificity (97·4%/99·0%, respectively). Our results indicate that immunoblot using soluble tachyzoite extract with simultaneous detection of at least three of the five bands (98, 36, 33, 32 and 21 kDa) represents a valuable test for serodiagnosis of acquired toxoplasmosis and should be further evaluated as a confirmatory test for sera which give discrepant results in quantitative assays.
- 27 November 2014
- Published by Wiley in Parasite Immunology
- Vol. 36 (12) , 684-693
Identification of soluble and membrane antigenic markers of acquired toxoplasmosis by immunoblot
Summary: The overall performance of quantitative assays in the detection of anti‐ToxoplasmaIgG is satisfactory, but discrepancies between assays are not uncommon especially when IgG concentrations are close to the limit of detection of the tests. The purpose of our study was to identify soluble and membrane antigens extracted fromToxoplasma gondiitachyzoites by immunoblot to select the most relevant antigenic bands to be used for qualitative serodiagnosis of acquired toxoplasmosis. We selected five relevant bands (98, 36, 33, 32 and 21 kDa) with soluble antigens and four relevant bands (42, 35, 32 and 30 kDa) with membrane antigens which gave high sensitivity and/or specificity in immunodiagnosis. The association on the same blot of at least three of the five relevant bands in the soluble antigen immunoblot showed the highest sensitivity/specificity (97·4%/99·0%, respectively). Our results indicate that immunoblot using soluble tachyzoite extract with simultaneous detection of at least three of the five bands (98, 36, 33, 32 and 21 kDa) represents a valuable test for serodiagnosis of acquired toxoplasmosis and should be further evaluated as a confirmatory test for sera which give discrepant results in quantitative assays.
- Open Access
- 22 October 2014
- Published by Korean Society for Parasitology in The Korean Journal of Parasitology
- Vol. 52 (5) , 493-499
A New IgG Immunoblot Kit for Diagnosis of Toxoplasmosis in Pregnant Women
Khammari I, et al. Korean J Parasitol. 2014 Oct;52(5):493-499. http://dx.doi.org/10.3347/kjp.2014.52.5.493
- 22 October 2014
- Published by Korean Society for Parasitology in The Korean Journal of Parasitology
- Vol. 52 (5) , 493-499
Open AccessA New IgG Immunoblot Kit for Diagnosis of Toxoplasmosis in Pregnant Women
Khammari I, et al. Korean J Parasitol. 2014 Oct;52(5):493-499. http://dx.doi.org/10.3347/kjp.2014.52.5.493
- Open Access
- 30 August 2013
- Published by Korean Society for Parasitology in The Korean Journal of Parasitology
- Vol. 51 (4) , 485-488
IgG Western Blot for Confirmatory Diagnosis of Equivocal Cases of Toxoplasmosis by EIA-IgG and Fluorescent Antibody Test
The performance values of available techniques used in serodiagnosis of toxoplasmosis are satisfactory but they raise problems of equivocal and discordant results for very low IgG titers. Recently marketed, LDBio-Toxo II IgG Western blot (IB) showed an excellent correlation with the dye test. We estimated the proportion of equivocal and discordant results between the enzyme immunoassay Platelia Toxo IgG (EIA-IgG) and fluorescent antibody test (FAT) and assessed the usefulness of the IB as a confirmatory test. Out of 2,136 sera collected from pregnant women, 1,644 (77.0%) tested unequivocally positive and 407 (19.0%) were negative in both EIA-IgG and FAT. The remaining 85 (4%) sera showed equivocal or discordant results. Among them, 73 (85.9%) were positive and 12 (14.1%) were negative in IB. Forty-one (89.1%) equivocal sera in EIA-IgG and 46 (86.8%) equivocal sera in FAT were positive in IB. Reducing the cut-off values of both screening techniques improved significantly their sensitivity in detecting very low IgG titers at the expense of their specificity. In conclusion, equivocal results in routine-used techniques and their discordance in determination of the immune status in pregnancy women were not uncommon. IB test appeard to be highly useful in these situations as a confirmatory technique.
- 30 August 2013
- Published by Korean Society for Parasitology in The Korean Journal of Parasitology
- Vol. 51 (4) , 485-488
Open AccessIgG Western Blot for Confirmatory Diagnosis of Equivocal Cases of Toxoplasmosis by EIA-IgG and Fluorescent Antibody Test
The performance values of available techniques used in serodiagnosis of toxoplasmosis are satisfactory but they raise problems of equivocal and discordant results for very low IgG titers. Recently marketed, LDBio-Toxo II IgG Western blot (IB) showed an excellent correlation with the dye test. We estimated the proportion of equivocal and discordant results between the enzyme immunoassay Platelia Toxo IgG (EIA-IgG) and fluorescent antibody test (FAT) and assessed the usefulness of the IB as a confirmatory test. Out of 2,136 sera collected from pregnant women, 1,644 (77.0%) tested unequivocally positive and 407 (19.0%) were negative in both EIA-IgG and FAT. The remaining 85 (4%) sera showed equivocal or discordant results. Among them, 73 (85.9%) were positive and 12 (14.1%) were negative in IB. Forty-one (89.1%) equivocal sera in EIA-IgG and 46 (86.8%) equivocal sera in FAT were positive in IB. Reducing the cut-off values of both screening techniques improved significantly their sensitivity in detecting very low IgG titers at the expense of their specificity. In conclusion, equivocal results in routine-used techniques and their discordance in determination of the immune status in pregnancy women were not uncommon. IB test appeard to be highly useful in these situations as a confirmatory technique.
- 1 June 2012
- Published by Elsevier in Pathologie Biologie
- Vol. 60 (3) , 160-165
Apport de l’immunoblot dans la détection des IgG anti-toxoplasmiques chez le sujet immunocompétent
- 1 June 2012
- Published by Elsevier in Pathologie Biologie
- Vol. 60 (3) , 160-165
Apport de l’immunoblot dans la détection des IgG anti-toxoplasmiques chez le sujet immunocompétent